However, GLP-1 receptor agonists are not recommended if you: - Are pregnant - Are hypersensitive to GLP-1 - Have severe gastrointestinal conditions like inflammatory bowel disease (IBD) - Are at a higher risk of certain thyroid cancers If you have a history of pancreatitis, kidney failure, or gallbladder disease, GLP-1 receptor agonists may not be safe for you
Coverage for Wegovy under Medicare or Medicaid varies according to federal and state regulations and individual plan details
Many candidates are midlife women, and roughly 70% of women experience weight gain during menopause, so overlapping perimenopausal hormone changes commonly complicate symptom attribution during GLP-1 treatment
From 2022 to 2023 alone, spending on GLP-1 RAs increased by 62% in the United States
Experiencing fatigue that peaks two days after injection
Most individuals with acute HBV infection are asymptomatic or have mild, self-limiting Self-Limiting Meningitis in Children symptoms